Central nervous system manifestations in rheumatic diseases

Journal of Medical Biochemistry

Volumn 30, Issue 1, 2011, Pages 1-4

  Cojocaru, Inimioara ^a   Cojocaru, Manole ^b   Silosi, Isabela ^c   Vrabie, Camelia ^d  

^a V Babes National Institute of Pathology   (Romania)

^b Center for Rheumatic Diseases   (Romania)

^c UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^d VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

Author keywords

neurological complications; rheumatic diseases

Indexed keywords

ANKYLOSING SPONDYLITIS; ANTIPHOSPHOLIPID SYNDROME; BEHCET DISEASE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHOREA; CLINICAL FEATURE; COGNITIVE DEFECT; COMA; DEATH; DEPRESSION; DERMATOMYOSITIS; DRUG INDUCED DISEASE; HEADACHE; HUMAN; HYPERTENSION; INCLUSION BODY MYOSITIS; NEUROLOGICAL COMPLICATION; POLYMYOSITIS; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SEIZURE; SJOEGREN SYNDROME; SPINAL CORD DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VASCULITIS;

EID: 78649663200     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-010-0014-y     Document Type: Review

References (30)

1. Nadeau SE. Neurological manifestations of connective tissue disease. Neurol Clin 2002; 20: 151-78.
2. Shannon KM, Goetz CG. Connective tissue diseases and the nervous system. In: Neurology and General Medicine. Edn 3. Edited by Aminoff MJ. Philadelphia: Churchill Livingstone; 2001; 459-81.
3. Turesson C, Matterson EL. Management of extra-articular disease manifestations in rheumatoid arthritis. Curr Opin Rheumatol 2004; 16: 206-11.
4. Kafeiska I, Spasovski D, Gruev T, Grlǐkov M, Cakalaroski K, Serafimovski V, Sotirova T, Milǒevski P. Association between osteoarticular scores and acute phase reactant levels in rheumatoid arthritis. Journal of Medical Biochemistry 2009; 28: 116-21.
5. Sanna G, Bertolaccini ML, Mathieu A. Central nervous system lupus: a clinical approach to therapy. Lupus 2003; 12: 935-42.
6. Chaves CJ. Stroke in patients with systemic lupus erythematosus and antiphospholipid antibody syndrome. Curr Treat Options Cardiovasc Med 2004; 6: 223-9.
7. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. Part I. Clinical syndromes: a literature investigation. Rheumatology 2002; 41: 605-18.
8. Olfat MO, Al-Mayouf SM, Muzaffer MA. Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus. Clin Rheumatol 2004; 23: 395-9.
9. Kovacs B, Lafferty T, Brent L, DeHoratius R. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 2000; 59: 120-4.
10. Jennekens FGI, Kater L. The central nervous system in systemic lupus erythematosus: Part 1. Clinical syndro mes: a literature investigation. Rheumatol 2002; 41: 605-18.
11. Mitsikostas DD, Sfikakis P P, Goadsb YPJ. A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain 2004; 127: 1200-9.
12. Katzav A, Chapman J, Shoenfeld Y. CNS dysfunction in the antiphospholipid syndrome. Lupus 2003; 12: 903-7.
13. Mosek A, Yust I, Treves TA, Vardinon N, Korczyn AD, Chapman J. Dementia and antiphospholipid antibo dies. Dement Geriatr Cogn Disord 2000; 11: 36-8.
14. Levine SR, Brey RL, Tilley BC. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004; 29: 576-84.
15. Tanne D. Epidemiology of antiphospholipid antibodies and vascular disease. In Clinical Approach to Anti phospholipid Antibodies. Edited by Levine SR and Brey R, Woburn MA: Butterworth-Heinemann 2000; 1-18.
16. 2-glycoprotein 1 in ische mic stroke. Cerebrovasc Dis 2000; 10: 293-7.
17. Younger D. Vasculitis and the nervous system. Curr Opin Neurol 2004; 17: 317-36.
18. Nagashima T, Maguchi S, Terayama Y, et al. P-ANCA-positive Wegener's granulomatosis presenting with hy per trophic pachymeningitis and multiple cranial neuro pathies: case report and review of literature. Neu ro pathology 2000; 20: 23-30.
19. Fam AG, Lavine E, Lee L, Perez-Ordonez B, Goyal M. Cranial pachymeningitis an unusual manifestation of Wegener's granulomatosis. J Rheumatol 2003; 30: 2070-4.
20. Reichhart MD, Bogousslavsky J, Janzer RC. Early lacunar strokes complicating polyarteritis nodosa: thrombotic microangiopathy. Neurology 2000; 54: 883-9.
21. Rosenblatt BJ, Foroozan R, Savino PJ. Asymptomatic optic neuropathy associated with Churg-Strauss syn drome. Ophtalmology 2003; 110: 1650-2.
22. Siva A, Altintas A, Saip S. Behçet's syndrome and the nervous system. Curr Opin Neurol 2004; 17: 347-57.
23. Evans RW, Akman-Demir G. Behçet syndrome and headache. Headache 2004; 44: 102-4.
24. Valtysdottir S T, Gudbjornsson B, Lindqvist U, et al. Anxiety and depression in patients with primary Sjögren's syndrome. J Rheumatol 2000; 27: 165-9.
25. Lafitte C, Amoura Z, Cacoub P, Prrradat-Diehl P, Picq C, Salachas F, Léger JM, Piette JC, Delattre J Y. Neurological complications of primary Sjögren's syndrome. J Neurol 2001; 248: 577-84.
26. Soliotis FC, Mavragani C P, Moutsopoulos HM. Central nervous system involvement in Sjögren's syndrome. Ann Rheum Dis 2004; 63: 616-20.
27. Pericot I, Brieva L, Tintore M, et al. Myelopathy in serone gative Sjögren syndrome and/or primary progressive multiple sclerosis. Mult Scler 2003; 9: 256-9.
28. Torabi AM, Patel RK, Wolfe GI, et al. Transverse myelitis in systemic sclerosis. Arch Neurol 2004; 61: 126-8.
29. Grosso S, Fioravanti A, Biasi G. Linear scleroderma associated with progressive brain atrophy. Brain Dev 2003; 25: 57-61.
30. Duzova A, Bakkaloglu A. Central nervous system involvement in pediatric rheumatic diseases: current concepts in treatment. Curr Pharm Des 2008; 14 (13): 1295-301.